H Ménard

5.2k total citations
19 papers, 338 citations indexed

About

H Ménard is a scholar working on Rheumatology, Pharmacology and Pharmacology. According to data from OpenAlex, H Ménard has authored 19 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 6 papers in Pharmacology and 4 papers in Pharmacology. Recurrent topics in H Ménard's work include Rheumatoid Arthritis Research and Therapies (6 papers), Inflammatory mediators and NSAID effects (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). H Ménard is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Inflammatory mediators and NSAID effects (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). H Ménard collaborates with scholars based in Canada, Netherlands and United States. H Ménard's co-authors include Gilles Boire, M. Lora, M C Gendron, René E. M. Toes, T. Huizinga, Diane van der Woude, Hans Ulrich Scherer, Leendert A. Trouw, Andreea Ioan‐Facsinay and A Lussier and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Annals of the Rheumatic Diseases and Clinical & Experimental Immunology.

In The Last Decade

H Ménard

18 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H Ménard Canada	7	203	130	91	54	48	19	338
B Liccardo Italy	9	53 0.3×	59 0.5×	130 1.4×	89 1.6×	15 0.3×	20	367
Mikhail Volkov Netherlands	7	128 0.6×	81 0.6×	84 0.9×	50 0.9×	4 0.1×	17	239
Masanobu Oishi Japan	3	76 0.4×	11 0.1×	183 2.0×	90 1.7×	17 0.4×	4	378
S K Babcock United States	8	103 0.5×	62 0.5×	280 3.1×	56 1.0×	3 0.1×	12	398
Scott Henderson United States	5	207 1.0×	38 0.3×	235 2.6×	29 0.5×	12 0.3×	7	374
M. C. Ábalos‐Aguilera Spain	8	148 0.7×	11 0.1×	151 1.7×	106 2.0×	7 0.1×	19	303
Biljana Smiljanovic Germany	9	146 0.7×	14 0.1×	158 1.7×	103 1.9×	9 0.2×	17	313
Ştefăniţă Tănăseanu Romania	6	58 0.3×	8 0.1×	97 1.1×	59 1.1×	12 0.3×	9	187
Takafumi Torigoshi Japan	10	90 0.4×	8 0.1×	86 0.9×	120 2.2×	12 0.3×	15	284
Ralph Lippe Germany	14	279 1.4×	13 0.1×	268 2.9×	32 0.6×	7 0.1×	26	469

Countries citing papers authored by H Ménard

Since Specialization

Citations

This map shows the geographic impact of H Ménard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Ménard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Ménard more than expected).

Fields of papers citing papers by H Ménard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Ménard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Ménard. The network helps show where H Ménard may publish in the future.

Co-authorship network of co-authors of H Ménard

This figure shows the co-authorship network connecting the top 25 collaborators of H Ménard. A scholar is included among the top collaborators of H Ménard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Ménard. H Ménard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Ménard, H, et al.. (2025). Fall Risk Assessment in Acute Rehabilitation: Comparison of Two Assessment Tools. Rehabilitation Nursing. 50(1). 24–32.

Ioan‐Facsinay, Andreea, Hans Ulrich Scherer, Diane van der Woude, et al.. (2010). Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Annals of the Rheumatic Diseases. 70(1). 188–193. 122 indexed citations

Boulanger, Chantal M., Benoı̂t Chabot, H Ménard, & Gilles Boire. (1995). Autoantibodies in human anti-Ro sera specifically recognize deproteinized hY5 Ro RNA. Clinical & Experimental Immunology. 99(1). 29–36. 22 indexed citations

Boire, Gilles, et al.. (1995). Purification of antigenically intact Ro ribonucleoproteins; biochemical and Immunological evidence that the 52-kD protein is not a Ro protein. Clinical & Experimental Immunology. 100(3). 489–498. 53 indexed citations

Laporte, Stéphane A., et al.. (1994). Expression of Prostaglandin-Endoperoxide Synthase 1 and Prostaglandin-Endoperoxide Synthase 2 in Human Osteoblasts. Biochemical and Biophysical Research Communications. 198(3). 955–960. 40 indexed citations

Dalpé, Gratien, Alain Béliveau, H Ménard, & Gilles Boire. (1994). Cross-reactivity of an anti-proteinase 3 antibody to elastase. Autoimmunity. 17(3). 253–255. 2 indexed citations

Kean, Walter F., W. Watson Buchanan, J.-P. Pelletier, et al.. (1993). Open study on the efficacy and safety of long-term use of SURGAM-SR (sustained-release form of tiaprofenic acid) in rheumatoid arthritis patients. Inflammopharmacology. 2(1). 63–70. 1 indexed citations

Boire, Gilles, H Ménard, M C Gendron, A Lussier, & D Myhal. (1993). Rheumatoid arthritis: anti-Ro antibodies define a non-HLA-DR4 associated clinicoserological cluster.. PubMed. 20(10). 1654–60. 28 indexed citations

Bellamy, Nicholas, A. D. Beaulieu, Claire Bombardier, et al.. (1992). Efficacy and tolerability of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis: A double-blind comparison with standard naproxen followed by an open-label trial. Current Medical Research and Opinion. 12(10). 640–651. 2 indexed citations

10.

Atkinson, Matthew, et al.. (1992). A comparison of tenoxicam and piroxicam in the treatment of rheumatoid arthritis.. PubMed. 19(4). 538–42. 4 indexed citations

11.

Corey, Paul, Mathew J. Willans, John Percy, et al.. (1988). Clinical evaluation of a new controlled-release formulation of naproxen in osteoarthritis and rheumatoid arthritis. Current Medical Research and Opinion. 11(1). 16–27. 5 indexed citations

12.

Harth, Manfred, Paul J. Davis, John Thompson, H Ménard, & F Beaudet. (1987). Comparison between Sodium Aurothiomalate and Auranofin in Rheumatoid Arthritis:Results of a Two-year Open Randomized Study. Scandinavian Journal of Rheumatology. 16(3). 177–184. 13 indexed citations

13.

Masson, Cécile, D Myhal, H Ménard, & A Lussier. (1986). [Fatal thrombopenic thrombotic purpura in a female patient with adult Still's disease].. PubMed. 53(6). 389–91. 5 indexed citations

14.

Davis, P, et al.. (1985). One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.. PubMed. 12(1). 60–7. 26 indexed citations

15.

Ménard, H, et al.. (1980). Skin temperature of the knee: an unrecognized physical sign of inflammatory disease of the knee.. PubMed. 122(4). 439–40. 5 indexed citations

16.

Ménard, H, et al.. (1980). [Colitis and drug-induced lupus: the role of salazopyrine].. PubMed. 109(9). 1326–30. 1 indexed citations

17.

Lussier, A, et al.. (1978). Inhibition of adjuvant-induced arthritis in the hyperuricemic rat. Inflammation Research. 8(5). 536–542. 3 indexed citations

18.

Lussier, A, et al.. (1976). A double-blind cross-over evaluation of ketoprofen and aspirin in rheumatoid arthritis. Scandinavian Journal of Rheumatology. 5(sup14). 99–104. 5 indexed citations

19.

Ménard, H, et al.. (1971). [Microangiopathic anemia and intravascular coagulation; association with muco-cancer and treatment with heparin].. PubMed. 100(10). 1955–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact